Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Int. J. Mol. Sci. 2013, 14(12), 23274-23288; doi:10.3390/ijms141223274
Review

Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis

1
, 2,* , 2
, 3
, 1,2
 and 2
Received: 22 September 2013; in revised form: 8 November 2013 / Accepted: 13 November 2013 / Published: 26 November 2013
(This article belongs to the collection Programmed Cell Death and Apoptosis)
View Full-Text   |   Download PDF [388 KB, uploaded 19 June 2014]
Abstract: Mevalonic aciduria, a rare autosomal recessive disease, represents the most severe form of the periodic fever, known as Mevalonate Kinase Deficiency. This disease is caused by the mutation of the MVK gene, which codes for the enzyme mevalonate kinase, along the cholesterol pathway. Mevalonic aciduria patients show recurrent fever episodes with associated inflammatory symptoms, severe neurologic impairments, or death, in early childhood. The typical neurodegeneration occurring in mevalonic aciduria is linked both to the intrinsic apoptosis pathway (caspase-3 and -9), which is triggered by mitochondrial damage, and to pyroptosis (caspase-1). These cell death mechanisms seem to be also related to the assembly of the inflammasome, which may, in turn, activate pro-inflammatory cytokines and chemokines. Thus, this particular molecular platform may play a crucial role in neuroinflammation mechanisms. Nowadays, a specific therapy is still lacking and the pathogenic mechanisms involving neuroinflammation and neuronal dysfunction have not yet been completely understood, making mevalonic aciduria an orphan drug disease. This review aims to analyze the relationship among neuroinflammation, mitochondrial damage, programmed cell death, and neurodegeneration. Targeting inflammation and degeneration in the central nervous system might help identify promising treatment approaches for mevalonic aciduria or other diseases in which these mechanisms are involved.
Keywords: mevalonate; inflammation; neurodegeneration; apoptosis mevalonate; inflammation; neurodegeneration; apoptosis
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Tricarico, P.M.; Marcuzzi, A.; Piscianz, E.; Monasta, L.; Crovella, S.; Kleiner, G. Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis. Int. J. Mol. Sci. 2013, 14, 23274-23288.

AMA Style

Tricarico PM, Marcuzzi A, Piscianz E, Monasta L, Crovella S, Kleiner G. Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis. International Journal of Molecular Sciences. 2013; 14(12):23274-23288.

Chicago/Turabian Style

Tricarico, Paola M.; Marcuzzi, Annalisa; Piscianz, Elisa; Monasta, Lorenzo; Crovella, Sergio; Kleiner, Giulio. 2013. "Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis." Int. J. Mol. Sci. 14, no. 12: 23274-23288.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert